SIU 2017 Prostate Cancer
Viewing 21-40 of 56 articles
SIU 2017: The Utility of Subsequent Prostate Biopsies for the Active Surveillance of Prostate Cancer when Genomics and MRI Are Negative
SIU 2017: Routine Use of Adjuvant Radiation After Radical Prostatectomy for Positive Surgical Margin: Not for All!
SIU 2017:Use of Radiation for Positive Surgical Margins in Prostate Cancer – argument for adjuvant radiotherapy
SIU 2017: Prostate-Specific Membrane Antigen-Radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
SIU 2017: Oligometastatic Bone Disease in Prostate Cancer Patients Treated on the TROG 03.04 RADAR Trial
SIU 2017: Artificial Intelligence (AI) Can More Efficiently Predict Prostate Cancer Compared with PSADT and PSAD
SIU 2017: Different Incidence of Prostate Cancer According to Metabolic Health Status: A Nationwide Cohort Study
SIU 2017: MRI As a Triage Test in Prostate Cancer Diagnostic Algorithm in Biopsy - Naïve Men: A Prospective Study
SIU 2017: Atypical Small Acinar Proliferation: Progression to Clinically Significant Prostate Cancer?
SIU 2017: Biojet – Real Time TRUS/MRI Fusion Biopsy of The Prostate: Value of Combining Targeted and Systematic Biopsies
SIU 2017: Transperineal Template-Guided Mapping Biopsy and Multiparametric MRI for Detection of Clinically Significant Prostate Cancer in Patients after initial Negative Trans-rectal Ultrasound-Guided Biopsy
SIU 2017: Combined Clinical Parameters and Multiparametric MRI for Advanced Risk Modeling of Prostate Cancer - Patient-Tailored Risk Stratification Can Reduce Unnecessary Biopsies
SIU 2017: Correlation of mpMRI Contours with 3-Dimensional 5mm Transperineal Prostate Mapping Biopsy within the PROMIS Trial Pilot: What Margins Are Required?